Class III · Lower riskRecall completed
BuPROPion HCL Tablets
Unlikely to cause harm — often a labeling or packaging issue.
Does this affect you?
Check your lot numberLot # 0113148, 0113149, 0113150, Exp: 04/18; 0113636, Exp: 06/18; 0114513, Exp: 10/18
Where it was soldNationwide in the US
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed Moisture Limits: Product tested out-of-specification for moisture content.
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Mckesson Packaging Services |
| NDC | 63739-706-10 |
Show the full FDA record
| Full product label | BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Princeton, NJ 08805, NDC: 63739-706-10 |
| Recalling firm | Mckesson Packaging Services |
| Distribution | Nationwide in the US |
| Quantity | 942 cartons |
| Recall initiated | 2017-05-30 |
| Report date | 2017-07-05 |
| Recall completed | 2020-02-06 |
| Recall number | D-0928-2017 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Concord NC United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.